DR LAL PATHLABS
Back to Balance Sheet
|
DR LAL PATHLABS Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹11 Cr | ₹10 Cr | ₹14 Cr | ₹13 Cr | ₹10 Cr |
What is the latest Contingent Liabilities ratio of DR LAL PATHLABS ?
| Year | Contingent Liabilities |
|---|---|
| Mar2025 | ₹11 Cr |
| Mar2024 | ₹10 Cr |
| Mar2023 | ₹14 Cr |
| Mar2022 | ₹13 Cr |
| Mar2021 | ₹10 Cr |
How is Contingent Liabilities of DR LAL PATHLABS Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹11 Cr | 4.99 | |
| Mar2024 | ₹10 Cr | -26.02 | |
| Mar2023 | ₹14 Cr | 3.43 | |
| Mar2022 | ₹13 Cr | 26.43 | |
| Mar2021 | ₹10 Cr | - | |
Compare Contingent Liabilities of peers of DR LAL PATHLABS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR LAL PATHLABS | ₹23,720.4 Cr | -1.7% | 8.3% | 2% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹112,436.0 Cr | 1% | 9.5% | 9% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹98,297.3 Cr | -1.1% | 5.6% | -11.4% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹71,996.6 Cr | 4.1% | 19.3% | 39.7% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹36,620.4 Cr | -0.7% | 10.3% | -3.6% | Stock Analytics | |
| GLOBAL HEALTH | ₹31,328.0 Cr | 7.7% | 20.3% | -13.3% | Stock Analytics | |
DR LAL PATHLABS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR LAL PATHLABS | -1.7% |
8.3% |
2% |
| SENSEX | -1.6% |
3.7% |
-2.7% |
You may also like the below Video Courses